Clinical Trial

Peeling of the Internal Limiting Membrane During Primary Vitrectomy for Retinal Detachment Repair

Terminated
View on ClinicalTrials.gov →
Why the trial stopped
Peeling of the internal limiting membrane has shown risks to leave full thickness retinal defects
Summary
Primary vitrectomy for retinal detachment repair is one of the current methods for surgical treatment of retinal detachment. Additional peeling of the internal limiting membrane (ILM) was reported to successfully prevent development of epiretinal membranes after surgery. The aim of the study is to examine the effect of ILM-Peeling on visual acuity outcomes and on occurrence of postoperative epiretinal membranes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-22.
Trial Details
NCT Number NCT07438210
Lead Sponsor Vienna Institute for Research in Ocular Surgery
Conditions Retinal Detachment
Enrollment 21 participants
Start Date 2019-04-03
Primary Completion 2025-01-01 (estimated)
Study Completion 2025-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-15